The success of pediatric cancer therapies has a downside: adults with lingering health problems caused by their treatments.
Using 3-D printers to create skull implants or replacement joints is exciting; running off living organs would be revolutionary.
Longitudinal studies have provided both puzzles and insights about human health and well being.
Can a new vaccine, injected intravenously, put the brakes on malaria?
As resistance to antibiotics grows, might phages, a treatment that fell out of favor decades ago, be the answer?
After 50 years, we take a look back at the pharmaceutical industry’s first $100 million brand.
The air you exhale carries a wealth of clinical data, and scientists are fashioning ever more precise methods for divining its truths.
Oncologist Donald Abrams confronts cancer with both conventional and integrative methods.
In this photo series, the imagination is the only limit for Luka, a young boy with spinal muscular atrophy.
Disease foundations that use a venture capital model get a stake in the breakthroughs they fund. Not everyone thinks that’s a good idea.
No Articles Found.